Powered by Google Google ÜbersetzerGoogle Übersetzer
Originaltext
Diese Übersetzung bewerten
Mit deinem Feedback können wir Google Übersetzer weiter verbessern
Latest Press Releases
View all
TimeHeadline
38m agoCactus Announces First Quarter 2026 Results
38m agoViridian Therapeutics Announces Pricing of Upsized Concurrent Public Offerings of 1.75% Convertible Senior Notes Due 2032 and Common Stock with Aggregate Gross Proceeds of $350.0 Million
39m agoCytokinetics Announces Pricing of Upsized Public Offering of Common Stock
1h agoMGE Energy, Inc. Prices Public Offering of 3,300,331 Shares of Common Stock
1h agoTravere Prices Upsized $475.0 Million Convertible Senior Notes Offering to Refinance 2029 Convertible Notes
Cumberland Pharmaceuticals Inc. logo

Cumberland Pharmaceuticals Inc.

About

Cumberland Pharmaceuticals Inc. — investor relations, events, news, and company updates on 6ix.

Latest News

May 5 2026
CUMBERLAND PHARMACEUTICALS REPORTS Q1 2026 FINANCIAL RESULTS & COMPANY UPDATE
Apr 28 2026
CUMBERLAND PHARMACEUTICALS TO ANNOUNCE Q1 2026 FINANCIAL RESULTS & COMPANY UPDATE
Apr 23 2026
Cumberland Pharmaceuticals Announces Strategic Transaction to Integrate Commercial Business with Apotex
Apr 16 2026
CUMBERLAND PHARMACEUTICALS ANNOUNCES EXPANDED INDICATION FOR CALDOLOR® (IBUPROFEN) INJECTION AND LAUNCH OF NEW BRAND WEBSITE
Mar 17 2026
Cumberland Pharmaceuticals Launches New Sancuso® Website Featuring Educational Resources for Chemotherapy-Induced Nausea and Vomiting

Community Chat

Ask AI

6ix6ix